Express Pharma

FDA lifts partial clinical hold on Gilead’s blood cancer drug trials

The health regulator had placed the hold on five cancer trials in January due to an imbalance in suspected and unexpected serious side effects between different arms of the studies that were reported by investigators of the trials

0 102